Background: Mycoplasma-related vaginitis gradually has been growing as a threat in adults-genitourinary infection contributes to funisitis, spontaneous abortion, and low birth weight. Until now, use of loop-mediated isothermal amplification (LAMP) to detect Ureaplasma urealyticum (UU), Mycoplasma hominis (MH), or Mycoplasma genitalium (MG) has been reported by some researchers. However, previous studies focused on purified DNA as the template for LAMP assay, which is usually extracted via commercial kit.
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The loop-mediated isothermal amplification (LAMP) assay uses 4 primers that recognize 6 regions on the target DNA, labeled F3, F2, F1, B1c, B2c, and B3. Four primers are divided into 2 groups, including 2 inner primers (forward inner primer [FIP] and backward inner primer [BIP] ) and 2 outer primers (F3 and B3). In the first round of the LAMP reaction, all 4 primers are used, but later during the cycling reaction, only the inner primers are used for strand-displacement DNA synthesis. 2 The specimens are amplified at a fixed temperature through a repetition of 2 types of elongation reactions occurring at the loop regions: self-elongation of templates from the stem loop structure formed at the 3′-terminal and the binding and elongation of new primers to the loop region. 3 The LAMP assay can amplify a few copies of DNA to 10 9 in less than 1 hour under isothermal conditions, which makes visible detection of specimens with positive results possible because of large quantities of by-products. 2 This functionality contrasts with traditional polymerase chain reaction (PCR), in which the reaction is performed by a thermal cycler and gel electrophoresis. The LAMP process is operated at constant temperature and does not require a thermal cycler. As a single-tube technique for nucleic acid amplification, the LAMP system provides improved specificity for rapid diagnosis of various diseases. In 2013, the World Health Organization (WHO) recommended the use of a commercial tuberculosis (TB)-LAMP assay for the detection of tuberculosis. Also, use of LAMP has been reported for detection of other pathogens, such as Clostridium difficile, 4 Ebola virus, 5 fungi and yeast, 6 hepatitis virus, 7 human immunodeficiency virus (HIV), 8 influenza virus, 9 methicillin-resistant Staphylococcus aureus (MRSA), 10 Neisseria meningitides, 11 Salmonella, 12 and
Staphylococcus aureus.
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In the present study, we aimed to test a method for point-ofcare testing based on LAMP for the rapid detection of UU, MH, and MG, especially for crude DNA template without DNA purification. This method may be useful in the future as a low-cost alternative to PCR in outpatient clinics for women in early pregnancy who have symptoms of vaginitis, as well as other patients with suspected genitourinary infections.
Materials and Methods

Bacterial Strains and DNA Extraction
We cultured UU (American Type Culture Collection [ATCC] 33699, Serovar 10), MH (ATCC 23114, PG21), and MG (ATCC 33530, G37) standard strains in ATCC-medium 2616, 243, and 988, respectively. Standard strains were inoculated aseptically into tightly sealed tissue-culture flasks containing freshly prepared medium and incubated at 37°C for several days. Growth was monitored by a pH-mediated color change of the medium. We extracted the genomic DNA of standard strains via TIANamp Bacteria DNA Kit (TIANGEN).
PCR Reactions
The primer sequences used for conventional PCR are listed as follows: UU forward 5′-CAATCTGCTCGTGAAGTATTAC-3′, UU reverse 5′-ACGACGTCCATAAGCAACT-3′ (amplicon 424 bp); MH forward 5′-TGAAAGGCGCTGTAAGGCGC-3′, MH reverse 5′-GTCTGCAATCATTTCCTATTGCAAA-3′ (amplicon 281 bp); MG forward 5′-AGTTGATGAAACC TTAACCCCTTGG-3′, MG reverse 5′-CCGTTGAGGGGTTTT CCATTTTTGC-3′ (amplicon 281 bp). The reaction was carried out in a total volume of 25 μL using a pair primers (10 μm each), <1 μg DNA, and 2× Taq After an initial denaturation at 94°C for 3 minutes, PCR amplification was performed with 30 cycles of denaturation (94°C for 30 seconds), annealing (55°C for 30 seconds), and extension (72°C for 1 minute), followed by an additional elongation at 72°C for 5 minutes. Thermal cycling was carried out using a TProfessional Thermocycler (Biometra GmbH). After staining with ethidium bromide, PCR reaction products were separated on 2% weight/volume agarose gels at 5 V/cm in 1× Tris-acetate-ethylenediaminetetraacetic acid (TAE) buffer for 1.5 hours. The photography was provided by the ChemiDoc XRS+ imaging system (Bio-Rad Laboratories, Inc).
LAMP Primer Design
The LAMP primers were selected from conserved regions of the UU, MH, and MG genomes, respectively. We designed external and internal primers for these regions using PrimerExplorer software, version 5.0 (http://www.primerexplorer.jp/e/), and synthesized the resulting data using the Biolytic Dr. 
Detection of LAMP Products
The amplification of the target DNA was observed by the naked eye based on direct visual information. A white precipitate indicated that the specimen had tested/would test positive, whereas in the absence of amplification, the reaction mixture became transparent and colorless. Real-time monitoring of turbidity was measured within 1 hour at 5-minute intervals from the start to the end of reaction using Loopamp Realtime Turbidimeter (LA-500, Eiken Chemical Co. Ltd). Also, the positive amplification showed a color change by illuminating with ultraviolet (UV) light after adding 2.5 μL of SYBR Green (1:1000 dilution of stock solution: Invitrogen; Thermo Fisher Scientific Inc) to each reaction. For further confirmation, 2 μl of each LAMP product stained with ethidium bromide were subjected to electrophoresis on 2% agarose gels at 5 V/cm in 1× TAE buffer for 1.5 hours and visualized by the ChemiDoc XRS+ imaging system (Bio-Rad Laboratories, Inc).
Process Optimization of UU-LAMP
A serial of temperatures from 55°C to 71°C at 2°C intervals and reaction time from 30 to 90 minutes at 15-minute intervals were detected, to optimize the process for UU-LAMP. The key parameters, including time and temperature, were analyzed via naked-eye visualization and gel electrophoresis.
Clinical Specimens and DNA Extraction
Thirty-one women with symptoms of vaginitis, abnormal vaginal discharge, and/or itching or burning in the genital area were prospectively enrolled at the Second Hospital of Tianjin Medical University, China. All enrolled subjects were sexually active women (self-reported) at 2 weeks to 8 weeks of pregnancy. Their ages ranged from 19 years to 37 years, with a median of 28 years. The institutional review board specifically approved the study; written informed consent was obtained from all participants. All examinations were performed in accordance with the ethical standards of the 1975 Declaration of Helsinki, as revised in 2013.
Vaginal swabs were used to collect specimens from the patients and transferred into sterile tubes containing 1 mL of special transport medium to keep them moist.
14 After thoroughly mixing, a 500-μL aliquot was removed for DNA extraction using a commercial kit (TIANGEN); the other aliquot was removed for crude DNA through boiling, as follows. Based on a slight modification of a previous method, 15 the specimens were centrifuged at 15,000 g for 3 minutes. After discarding the supernatant, the pellet was resuspended in 50 μL molecular biology-grade water and subjected to boiling at 100°C in a water bath for 5 minutes. The specimens were then cooled on ice and centrifuged at 15,000 g for 2 minutes. Finally, the supernatant was collected as a DNA template before it was stored at −20°C.
DNA Sequencing
DNA bands obtained from the positive UU-LAMP reactions on agarose gel were extracted via a PCR purification kit (QIAGEN) and then sequenced by using the Applied Biosystems 3730XL instrument (Thermo Fisher Scientific Inc). The primer sequences used for DNA sequencing are listed as follows: UU forward 5′-GAAGGCGAAAATGTGATGAAC-3′); UU reverse, 5′-GTTCTTTGTCTTCGTTTCCTT-3′. DNA sequencing was performed in a total volume of 20 μL of mixture using BigDye Terminator v3. 
Statistics
Crude DNA extracted by boiling specimen material collected from 31 vaginal swabs was detected by conventional PCR and UU-LAMP with optimized procedures, respectively. We compared the UU-LAMP and conventional PCR using crude DNA with standard PCR with purified DNA, which was considered the criterion standard. We carried out evaluation of the diagnostic assay using SPSS software, version 22.0 (SPSS, Inc); and P values less than .05 were considered statistically significant.
Results
The Ultimate Primers for UU, MH, and MG
The scheme of LAMP primer selection was shown in Figure 1 . Fourteen primer sets for UU, 15 sets for MH, and 8 sets for MG were generated in the first round of selection (Supplemental Tables 1-3) . Considering the inclusion and exclusion criteria on length, melting temperature (Tm), guanine and cytosine, respectively (GC) rate, dG threshold (dimer forming potential), and distances, there were 12, 14, and 8 sets of primers left for UU, MH, and MG, respectively. The primers were then used in LAMP reactions, and the products were analyzed using gel electrophoresis. Amplification products were observed as a ladder-like pattern on the agarose gel. Three sets of primer for UU (Figure 2A ), 10 sets for MH ( Figure 2B) , and 3 sets for MG ( Figure 2C ) led to successful LAMP reactions by electrophoresis. We tested primers in positive tubes for turbidity using the Loopamp Realtime Turbidimeter (LA-500; Eiken Chemical Co., Ltd). The ultimate primers were confirmed for UU ( Figure 2D ), MH ( Figure 2E ), and MG ( Figure 2F) , which induced the LAMP amplicons within the shortest time period. Consequently, LAMP primers of UU targeted at the urease gene (no. 3; Genbank: M36190.1), MH targeted at the gap gene (no. 11; Genbank: AJ243692.1), and MG targeted at 16S rRNA (no. 6; Genbank: NR_074611.1) were confirmed to be the most appropriate ones (Figure 3 ).
Sensitivity and Specificity of UU-LAMP
Successful amplification with LAMP primers of UU urease, MH gap, and MG 16S rRNA genes were achieved in specimen tubes containing each type of target DNA. A positive LAMP reaction generated a ladder-like pattern with several bands of different sizes on gel electrophoresis after incubation at 61°C for 60 minutes. The sensitivity of LAMP reaction was detected by using 10× serial dilutions from 100 ng through 1 pg. The detection limit of LAMP was 10 pg for UU and 100 pg for MH F2/B2 = 59~61ºC; F3/B3 = 59~61ºC 3) GC rate: 40%~65% 4) dG threshold: 5' stability = -3; 3' stability = -4; dimer check = -2.5 4) Distances: F2/B2 = 120~180; F2-F3 = 0~20; F1c-B1c = 0~100
Figure 1
The workflow of loop-mediated isothermal amplification (LAMP) primer selection. Primers for Ureaplasma urealyticum (UU), Mycoplasma hominis (MH), and Mycoplasma genitalium (MG) were designed using PrimerExplorer version 5.0 software (http://www.primerexplorer. jp/e/) online. After 3 rounds of screening testing, the ultimate primers were confirmed for UU (no. 3), MH (no. 11), and MG (no. 6). See Supplemental Tables 1-3 for primer sets in detail.
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and MG, indicating that it was 100 to 1000 times more sensitive than conventional PCR (Supplemental Figures 1A-1F ). For the specificity of LAMP, there was no cross-reactivity with DNA from other bacterial species (Supplemental Figures 1G-1I ).
Optimal Temperature and Time of LAMP
The optimum temperature or time was defined as the average temperature or time that induces the most products. The reaction time ranged from 30 minutes to 90 minutes and had no influence on the results of UU-LAMP; therefore, the optimal time was established as 60 minutes (Supplemental Figure 2A) . There was no striking difference from 55°C to 71°C on the products of UU-LAMP using primer set 3; however, temperature higher than 68°C resulted in inhibition of reaction (Supplemental Figure  2B) . Thus, the optimal temperature for UU-LAMP was determined to be 61°C. By using the same criteria, the optimal time and temperature for MH and MG were 60 minutes/65°C (Supplemental Figure 3) and 60 minutes/63°C (Supplemental Figure 4) , respectively.
UU-LAMP for Clinical Specimen Detection
To compare LAMP and PCR in application of crude DNA, we examined 31 swabs collected during early pregnancy from patients suspected of having vaginitis ( Figure 4) . Two specimens (in lane 4 and lane 10) were found to have positive results via LAMP and PCR testing. However, another 5 specimens with negative PCR results were also determined to have positive results via UU-LAMP (lanes 1, 3, 6, 7, and 8). All 7 clinical specimens with positive electrophoresis results also tested positive by visual detection of color change (and vice versa), suggesting the superior reliability of visual detection compared with gel electrophoresis ( Figure  4C-4D) . Moreover, all 7 specimens with positive LAMP reactions were confirmed using Sanger sequencing. The specimen in lane 10 was found to have positive results via PCR and LAMP; the DNA sequencing of the latter is shown in Figure 5 . Another specimen in lane 8 tested negative via PCR but positive via LAMP, which was validated by Sanger sequencing (Supplemental Figures  5-6 and Table 4 ). When using standard PCR with purified DNA as the criterion standard, the sensitivities in clinical specimens with crude DNA were 87.5% (95% confidence interval [CI], 64.6%-.99%) and 25.0% (95% CI, 0-55.0%) for UU-LAMP and PCR, respectively. For crude DNA specimens, UU-LAMP was more sensitive and reliable than PCR, with a higher agreement rate (96.8%) and Youden index value (0.88). These results
Figure 2
Primer show that LAMP offers potential advantages over PCR for lower cost and larger scale with consistent performance, in testing crude DNA.
MH-LAMP and MG-LAMP for Clinical Specimen Detection
To validate the use of LAMP in clinical specimens, MH and MG were detected via PCR and LAMP. For the detection of MH, only 1 specimen (lane 9) was found to test positive via LAMP for crude DNA, which was inconsistent with PCR for purified DNA (Supplemental Figure 7) . Regarding MG, 1 specimen (in lane 10) tested positive via LAMP for crude DNA and PCR for purified DNA (Supplemental Figure 8) .
However, no specimen that tested positive by any other method was found by PCR to have a positive result for crude DNA, which indicates that LAMP has great advantages over PCR as a method of point-of-care testing.
Discussion
We developed the LAMP assay amplification as a point-ofcare test for the detection of UU, MH, and MG. Using the optimized procedure, LAMP was successful for use analyzing specimens from vaginal swabs without the need for DNA extraction. Also, UU-LAMP enables detection of amplification by visual inspection, suggesting that the only equipment needed to perform a LAMP assay is pipettes for the liquid handling
Figure 3
Localization of ultimate loop-mediated isothermal amplification (LAMP) primers in sequences of Ureaplasma urealyticum (UU; no. 3; Genbank: M36190.1), Mycoplasma hominis (MH; no. 11; Genbank: AJ243692.1), and Mycoplasma genitalium (MG; no. 6; Genbank: NR_074611.1). FIP indicates forward inner primer; BIP, backward inner primer; F3, forward outer primer; F2, first attachment site of FIP primer; F1, second attachment site of FIP primer; B1c, first attachment site of BIP primer; B2c, second attachment site of BIP primer; B3c, attachment site for B3 primer.
DOI: 10.1093/labmed/lmx063 during the reaction setup and a single heating system used to maintain isothermal temperature. A simple thermal heater, such as a chemical pouch or bottle warmer, recently has been used in an effort to remove the dependence on stable electricity and to allow for LAMP to be conducted at any time outside well-equipped hospitals or laboratories. Thus, the technique has great potential for diagnostic work and research in different levels of clinics and point-of-care testing, especially in low-and middle-income countries. WHO has recommended TB-LAMP as a potential point-of-care test for tuberculosis in resource-limited settings. As a result, there is great potential for LAMP as a point-of-care test for the diagnosis of mycoplasma without thermocycling equipment, especially in resource-limited settings.
As potential tools for FDA-approved point-of-care testing, the application of LAMP has certain limitations. First, methods of multiple amplification in 1 tube aimed at several targets or different pathogens are less developed for LAMP than for PCR. There are a larger number of primer sets in LAMP assay, namely, 4 (or 6) primers targeting 6 (or 8) regions. This fact increases the likelihood of primer-primer interactions. Second, a higher risk of amplicon contamination occurs in LAMP because the tubes have to be opened to add the dye. However, false-positive and contamination results would be distinguished easily through sequencing and restriction-enzyme analysis. 16 To reduce the chances of contamination, more work is needed to develop a closed reaction system that does not involve laboratory workers opening tubes. 17 Use of LAMP to detect UU, MH, or MG has been reported by some researchers. 18 However, previous studies focused on purified DNA as the template for LAMP assay, which is usually extracted by use of a commercial kit. The time-consuming DNA purification process makes LAMP complicated in specimen preparation, which reduces its usefulness as a method of point-of-care testing.
In this study, we developed a LAMP assay for rapid detection of UU, MH, and MG using a simple boiling method for DNA extraction. According to a previous report, 19 the LAMP assay probably requires more integrity of the target, owing to the many primers that need to be annealed to the different regions. There may have been partial degradation of target DNA in the process of specimen boiling. However, the UU-LAMP developed in this study was more sensitive and reliable than traditional PCR. In concordance with previous results, LAMP showed 100-fold greater sensitivity than conventional PCR. 20 One possibility is that Bst DNA polymerase has higher activity than the standard Taq. UU, MH, and MG are common urogenital mycoplasmas, especially in the genital tracts of sexually active and/or pregnant women. These mycoplasmas pose a serious medical threat to the mother during gestation and to the fetus and neonate. 21 Bayraktar et al 22 found that 54.0% (27/50) of pregnant women experiencing symptoms had UU and/ or MH infection, and 12 women in the patient group experienced spontaneous abortion at a gestation period of less than 36 weeks. Our population-based cohort study showed, via UU-LAMP, a relative low prevalence of mycoplasmas in pregnant women (7/31 [22.6%]), probably because this population is more likely to act conservatively regarding sex compared with populations in the United States and Europe. However, detection of genital mycoplasmas is of great importance for pregnant women to prevent preterm birth, low birth weight, and miscarriage. UU and MH coinfection is often addressed in the literature. 23 Future work on UU, MH, and MG will continue to disclose the relationship of these entities to adverse events during pregnancy.
The LAMP assay potentially can be developed for point-ofcare testing because of its simple visual and colorimetric detection of amplicons, including turbidity visible by the naked eye and visual fluorescence detectable by UV light. To improve visual inspection, reactions can be observed for white color and turbidity after a pulse spin to deposit the precipitate in the bottom of the tube, or adding metal-ion indicators in the reaction system. In some cases,
Figure 5
Representative images of positive Ureaplasma urealyticum (UU)-loop-mediated isothermal amplification (LAMP) products by Sanger sequencing and capillary electrophoresis. The fragment of lane 10 was sequenced with forward (A) and reverse (B) primers. (C) The target fragment in the electropherogram reading is consistent with the UU sequence (100% identity).
the increase in turbidity can be difficult to detect with the naked eye. Thus, the tube containing the LAMP amplicons can be visualized more effectively in the presence of fluorescent DNA-intercalating dyes, such as ethidium bromide, EvaGreen (Biotium), GelRed (Biotium), GeneFinder (Baygene Biotech Co Ltd), Malachite green (Sigma-Aldrich Co, LLC), PicoGreen (Thermo Fisher Scientific Inc), SYBR Green I (Thermo Fisher Scientific Inc), SYBR Premix EX Taq II (Takara Bio Inc), and SYTO-9 (Thermo Fisher Scientific Inc).
In this study, LAMP was evaluated as a diagnostic assay for pregnant women suspected of having vaginitis. As a pointof-care test, LAMP is a useful, specific, and efficient way to detect genital mycoplasmas in resource-limited settings without any need for expensive equipment or specialized techniques, especially for crude DNA extracted by boiling.
Further research in large-scale cohorts for evaluation of LAMP for detection of genital mycoplasmas will be needed to reach standardization and acceptance of this new technology, which potentially could be used to guide therapeutic decision-making. LM
